Biofourmis Inc. Sustainability Profile
Biofourmis Inc., headquartered in the United States, is a pioneering force in the digital health industry, specialising in advanced biopharmaceutical solutions and personalised patient care. Founded in 2015, the company has rapidly established itself as a leader in the development of innovative software and wearable technologies that enhance patient monitoring and treatment outcomes. With a focus on harnessing artificial intelligence and machine learning, Biofourmis offers unique products such as its Biovitals® platform, which provides real-time insights into patient health. This technology not only improves clinical decision-making but also optimises therapeutic interventions. Recognised for its significant contributions to the healthcare sector, Biofourmis has achieved notable milestones, including partnerships with leading healthcare providers and successful clinical trials, solidifying its position as a key player in the evolving landscape of digital therapeutics.
DitchCarbon Score
How does Biofourmis Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Research Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Biofourmis Inc.'s score of 23 is lower than 70% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Biofourmis Inc.'s reported carbon emissions
Biofourmis Inc., headquartered in the US, currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Additionally, there are no documented reduction targets or climate pledges associated with the company. This lack of data suggests that Biofourmis may not have established formal commitments to reduce its carbon footprint or may be in the early stages of developing such initiatives. In the context of the industry, many companies are increasingly adopting science-based targets and sustainability commitments to address climate change. However, without specific emissions data or reduction initiatives, it is challenging to assess Biofourmis' position relative to its peers in the healthcare technology sector.
How Carbon Intensive is Biofourmis Inc.'s Industry?
How Carbon Intensive is Biofourmis Inc.'s Location?
Biofourmis Inc.'s Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Biofourmis Inc. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
